D
Daniela Lazăr
Publications - 38
Citations - 1439
Daniela Lazăr is an academic researcher. The author has contributed to research in topics: Cancer & Inflammatory bowel disease. The author has an hindex of 19, co-authored 36 publications receiving 1195 citations.
Papers
More filters
Journal ArticleDOI
East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
Johan Burisch,Niels C Pedersen,Silvija Čuković-Čavka,Marko Brinar,I. Kaimakliotis,Dana Duricova,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Vibeke Andersen,Simon Laiggard Krabbe,Jens Frederik Dahlerup,Riina Salupere,K R Nielsen,J. Olsen,Pekka Manninen,Pekka Collin,E.V. Tsianos,Konstantinos Katsanos,K. Ladefoged,Laszlo Lakatos,Einar Björnsson,G. Ragnarsson,Y. Bailey,Shmuel Odes,Doron Schwartz,Matteo Martinato,Guido Lupinacci,Monica Milla,A. De Padova,Renata D'Incà,M Beltrami,Limas Kupčinskas,Gediminas Kiudelis,Svetlana Turcan,O Tighineanu,I Mihu,Fernando Magro,Fernando Magro,L. Barros,Adrian Goldis,Daniela Lazăr,Elena Belousova,Inna Nikulina,Veronica Moset Hernandez,D. Martinez-Ares,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Naila Arebi,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +54 more
TL;DR: Whether an East–West gradient in the incidence of inflammatory bowel disease in Europe exists is investigated to find out whether international guidelines for diagnosis and initial treatment are not being followed uniformly by physicians.
Journal ArticleDOI
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer.
Daniela Lazăr,Mihaela Flavia Avram,Ioan Romoșan,Marioara Cornianu,Sorina Tăban,Adrian Goldiș +5 more
TL;DR: Understanding the complex relationship between the host immune microenvironment and tumor and the immune escape phenomenon leading to cancer occurrence and progression will subsequently lead to the identification of prognostic immune markers, which will result in the discovery of both new mechanisms for blocking tumor immunosuppressive signals and pathways to stimulate the local immune response.
Journal ArticleDOI
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
Z. Vegh,Z. Vegh,Johan Burisch,Niels C Pedersen,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Søren Avnstrøm,K. Kofod Vinding,J. Olsen,K R Nielsen,K.H. Katsanos,E.V. Tsianos,Laszlo Lakatos,Doron Schwartz,Shmuel Odes,Guido Lupinacci,A. De Padova,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,O Tighineanu,I Mihu,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Alberto Fernandez,Vicent Hernandez,O Niewiadomski,Sally Bell,Ebbe Langholz,Pia Munkholm,Peter L. Lakatos,EpiCom-group +34 more
TL;DR: Incidence rates, disease phenotype and initial treatment characteristics in the 2011 ECCO-EpiCom cohort were not significantly different from that reported in the 2010 cohort.
Journal ArticleDOI
Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study
Johan Burisch,Niels C Pedersen,Silvija Čuković-Čavka,Nikša Turk,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Susanne Krabbe,Vibeke Andersen,Jens Frederik Dahlerup,Jens Kjeldsen,Riina Salupere,J. Olsen,K R Nielsen,Pia Manninen,Pekka Collin,K.H. Katsanos,E.V. Tsianos,K. Ladefoged,Laszlo Lakatos,G. Ragnarsson,Einar Bjornsson,Y. Bailey,Colm O'Morain,Doron Schwartz,Shmuel Odes,M. Giannotta,G. Girardin,Gediminas Kiudelis,Limas Kupčinskas,Svetlana Turcan,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Inna Nikulina,Elena Belousova,David Martínez-Ares,Vicent Hernandez,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Naila Arebi,H. H. Tsai,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +51 more
TL;DR: In this European population-based inception cohort of unselected IBD patients, Eastern and Western European patients differing in environmental factors prior to diagnosis exhibited higher occurrences of suspected risk factors for IBD included in the Western lifestyle.
Journal ArticleDOI
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort
Johan Burisch,Natalia Pedersen,S. Cukovic-Cavka,Nikša Turk,I. Kaimakliotis,Dana Duricova,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Susanne Krabbe,Vibeke Andersen,Vibeke Andersen,Frederik Dahlerup Jens,Jens Kjeldsen,Riina Salupere,Jóngerd Olsen,K R Nielsen,Pia Manninen,Pekka Collin,Konstantinnos H. Katsanos,Epameinondas V. Tsianos,K. Ladefoged,Laszlo Lakatos,Y. Bailey,Colm O'Morain,Doron Schwartz,Selwyn Odes,Matteo Martinato,Silvia Lombardini,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Inna Nikulina,Elena Belousova,Alberto Fernandez,Vicent Hernandez,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Her Hsin Tsai,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +48 more
TL;DR: Surgery and hospitalization rates did not differ between patients from eastern and western Europe, although more western European patients received biological agents and were comparable to previous population-based inception cohorts.